ISonea Limited Announces Publication Of Initial Viriathus...

ISonea Limited Announces Publication Of Initial Viriathus Research Report
By Business Wire 01/03/12 - 08:00am



iSonea Ltd. (ASX: ISN);(OTCQX: ISOAY), an emerging medical technology company developing innovative monitoring systems and software for the management of asthma, today announced that Viriathus Research LLC has issued an initial informational research report on the Company.

iSonea’s American Depositary Receipts (ADRs) began trading today on the OTCQX marketplace in the U.S. under the symbol ISOAY.

Commercial strategy for development and launch of the first Acoustic Respiratory Monitoring devices that allow anyone to monitor breathing symptoms anywhere, at anytime;

Enormous opportunity to address unmet needs in the rapidly growing asthma market, both in the U.S. and worldwide;

New management team with successful track record of growing innovative medical technology companies.

“We are pleased to see the publication of this report by Viriathus, which will help to increase the visibility of our opportunity to investors focused on novel medical and mobile health technology,” said Michael J. Thomas, Chief Executive Officer.

Interested parties may download a copy of the Viriathus Research report on iSonea by accessing the Viriathus Research archive at www.viriathus